Skip to main content

Main menu

  • Home
  • Content
    • Latest
    • Archive
    • home
  • Info for
    • Authors
    • Reviewers
    • Subscribers
    • Institutions
    • Advertisers
    • Join SMJ
  • About Us
    • About Us
    • Editorial Office
    • Editorial Board
  • More
    • Advertising
    • Alerts
    • Feedback
    • Folders
    • Help
  • Other Publications
    • NeuroSciences Journal

User menu

  • My alerts
  • Log in

Search

  • Advanced search
Saudi Medical Journal
  • Other Publications
    • NeuroSciences Journal
  • My alerts
  • Log in
Saudi Medical Journal

Advanced Search

  • Home
  • Content
    • Latest
    • Archive
    • home
  • Info for
    • Authors
    • Reviewers
    • Subscribers
    • Institutions
    • Advertisers
    • Join SMJ
  • About Us
    • About Us
    • Editorial Office
    • Editorial Board
  • More
    • Advertising
    • Alerts
    • Feedback
    • Folders
    • Help
  • Follow psmmc on Twitter
  • Visit psmmc on Facebook
  • RSS
Research ArticleOriginal Article
Open Access

Prevalence and treatment outcomes of second primary malignancies in Saudi patients with differentiated thyroid cancers

Khalid H. Al-Qahtani, Mushabbab Al-Asiri, Mutahir A. Tunio, Naji J. Aljohani, Yasser Bayoumi, Hussain Al-Hussain and Ahmed M. Maklad
Saudi Medical Journal January 2015, 36 (4) 442-448; DOI: https://doi.org/10.15537/smj.2015.4.10341
Khalid H. Al-Qahtani
From the Department of Otolaryngology - Head and Neck Surgery (Al-Qahtani), College of Medicine, King Saud University, the Department of Radiation Oncology (Al-Assiri, Tunio, Al-Hussain), Comprehensive Cancer Center, the Department of Endocrinology and Thyroid Oncology (Aljohani), King Fahad Medical City, Riyadh, Kingdom of Saudi Arabia, the Department of Radiation Oncology (Bayoumi), National Cancer Institute, Cairo University, Cairo, and the Department of Clinical Oncology (Maklad), Sohag University, Sohag, Egypt
MD, FRCSC
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mushabbab Al-Asiri
From the Department of Otolaryngology - Head and Neck Surgery (Al-Qahtani), College of Medicine, King Saud University, the Department of Radiation Oncology (Al-Assiri, Tunio, Al-Hussain), Comprehensive Cancer Center, the Department of Endocrinology and Thyroid Oncology (Aljohani), King Fahad Medical City, Riyadh, Kingdom of Saudi Arabia, the Department of Radiation Oncology (Bayoumi), National Cancer Institute, Cairo University, Cairo, and the Department of Clinical Oncology (Maklad), Sohag University, Sohag, Egypt
MBBS, FRCSI (Clin Oncol)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mutahir A. Tunio
From the Department of Otolaryngology - Head and Neck Surgery (Al-Qahtani), College of Medicine, King Saud University, the Department of Radiation Oncology (Al-Assiri, Tunio, Al-Hussain), Comprehensive Cancer Center, the Department of Endocrinology and Thyroid Oncology (Aljohani), King Fahad Medical City, Riyadh, Kingdom of Saudi Arabia, the Department of Radiation Oncology (Bayoumi), National Cancer Institute, Cairo University, Cairo, and the Department of Clinical Oncology (Maklad), Sohag University, Sohag, Egypt
MBBS, FCPS (Rad Oncol)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: [email protected]
Naji J. Aljohani
From the Department of Otolaryngology - Head and Neck Surgery (Al-Qahtani), College of Medicine, King Saud University, the Department of Radiation Oncology (Al-Assiri, Tunio, Al-Hussain), Comprehensive Cancer Center, the Department of Endocrinology and Thyroid Oncology (Aljohani), King Fahad Medical City, Riyadh, Kingdom of Saudi Arabia, the Department of Radiation Oncology (Bayoumi), National Cancer Institute, Cairo University, Cairo, and the Department of Clinical Oncology (Maklad), Sohag University, Sohag, Egypt
MD, FRCPC
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Yasser Bayoumi
From the Department of Otolaryngology - Head and Neck Surgery (Al-Qahtani), College of Medicine, King Saud University, the Department of Radiation Oncology (Al-Assiri, Tunio, Al-Hussain), Comprehensive Cancer Center, the Department of Endocrinology and Thyroid Oncology (Aljohani), King Fahad Medical City, Riyadh, Kingdom of Saudi Arabia, the Department of Radiation Oncology (Bayoumi), National Cancer Institute, Cairo University, Cairo, and the Department of Clinical Oncology (Maklad), Sohag University, Sohag, Egypt
MBBCH, MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Hussain Al-Hussain
From the Department of Otolaryngology - Head and Neck Surgery (Al-Qahtani), College of Medicine, King Saud University, the Department of Radiation Oncology (Al-Assiri, Tunio, Al-Hussain), Comprehensive Cancer Center, the Department of Endocrinology and Thyroid Oncology (Aljohani), King Fahad Medical City, Riyadh, Kingdom of Saudi Arabia, the Department of Radiation Oncology (Bayoumi), National Cancer Institute, Cairo University, Cairo, and the Department of Clinical Oncology (Maklad), Sohag University, Sohag, Egypt
MD, FRCPC
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ahmed M. Maklad
From the Department of Otolaryngology - Head and Neck Surgery (Al-Qahtani), College of Medicine, King Saud University, the Department of Radiation Oncology (Al-Assiri, Tunio, Al-Hussain), Comprehensive Cancer Center, the Department of Endocrinology and Thyroid Oncology (Aljohani), King Fahad Medical City, Riyadh, Kingdom of Saudi Arabia, the Department of Radiation Oncology (Bayoumi), National Cancer Institute, Cairo University, Cairo, and the Department of Clinical Oncology (Maklad), Sohag University, Sohag, Egypt
MBBCH, MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • eLetters
  • Info & Metrics
  • References
  • PDF
Loading

Article Information

vol. 36 no. 4 442-448
DOI 
https://doi.org/10.15537/smj.2015.4.10341
PubMed 
25828281

Published By 
Saudi Medical Journal
Online ISSN 
1658-3175
History 
  • Published online April 1, 2015.

Copyright & Usage 
Copyright: © Saudi Medical Journal This is an open-access article distributed under the terms of the Creative Commons Attribution-Noncommercial-Share Alike 3.0 Unported, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Author Information

  1. Khalid H. Al-Qahtani, MD, FRCSC,
  2. Mushabbab Al-Asiri, MBBS, FRCSI (Clin Oncol),
  3. Mutahir A. Tunio, MBBS, FCPS (Rad Oncol)⇑,
  4. Naji J. Aljohani, MD, FRCPC,
  5. Yasser Bayoumi, MBBCH, MD,
  6. Hussain Al-Hussain, MD, FRCPC and
  7. Ahmed M. Maklad, MBBCH, MD
  1. From the Department of Otolaryngology - Head and Neck Surgery (Al-Qahtani), College of Medicine, King Saud University, the Department of Radiation Oncology (Al-Assiri, Tunio, Al-Hussain), Comprehensive Cancer Center, the Department of Endocrinology and Thyroid Oncology (Aljohani), King Fahad Medical City, Riyadh, Kingdom of Saudi Arabia, the Department of Radiation Oncology (Bayoumi), National Cancer Institute, Cairo University, Cairo, and the Department of Clinical Oncology (Maklad), Sohag University, Sohag, Egypt
  1. Address correspondence and reprint request to: Dr. Mutahir A. Tunio, Department of Radiation Oncology, Comprehensive Cancer Center King Fahad Medical City, PO Box 59046, Riyadh 11525, Kingdom of Saudi Arabia. Fax. +966 (11) 889999. E-mail: drmutahirtonio{at}hotmail.com
View Full Text

Cited By...

  • 4 Citations
  • Google Scholar

This article has been cited by the following articles in journals that are participating in Crossref Cited-by Linking.

  • A Systematic Review and Meta-Analysis of Subsequent Malignant Neoplasm Risk After Radioactive Iodine Treatment of Thyroid Cancer
    Chi Yun Yu, Omar Saeed, Alyse S. Goldberg, Shafaq Farooq, Rouhi Fazelzad, David P. Goldstein, Richard W. Tsang, James D. Brierley, Shereen Ezzat, Lehana Thabane, Charlie H. Goldsmith, Anna M. Sawka
    Thyroid 2018 28 12
  • Synchronous double primary lymphoma and thyroid cancer
    Qiuhui Li, Fang Zhu, Yin Xiao, Tao Liu, Xinxiu Liu, Liling Zhang, Gang Wu
    Medicine 2021 100 39
  • Second Primary Malignancies in Patients with Differentiated Thyroid Cancer after Radionuclide Therapy: A Retrospective Single-Centre Study
    Leandra Piscopo, Fabio Volpe, Carmela Nappi, Emilia Zampella, Mariarosaria Manganelli, Francesca Matrisciano, Pasquale Totaro, Leonardo Pace, Simone Maurea, Alberto Cuocolo, Michele Klain
    Current Oncology 2022 30 1
  • Assessment of Patients’ Quality-of-Life Post-Thyroidectomy
    Sahar M Alnefaie, Muath S Alotaibi, Abdullah E Alsobaie, Wafi B Alotaibi, Mohammad I Alwuthaynani, Ahmed R Alotibi, Fahad A Alayyaf, Rasan F Almnjwami
    Cureus 2024
PreviousNext
Back to top

In this issue

Saudi Medical Journal: 36 (4)
Saudi Medical Journal
Vol. 36, Issue 4
1 Jan 2015
  • Table of Contents
  • Cover (PDF)
  • Index by author
Print
Download PDF
Email Article

Thank you for your interest in spreading the word on Saudi Medical Journal.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Prevalence and treatment outcomes of second primary malignancies in Saudi patients with differentiated thyroid cancers
(Your Name) has sent you a message from Saudi Medical Journal
(Your Name) thought you would like to see the Saudi Medical Journal web site.
Citation Tools
Prevalence and treatment outcomes of second primary malignancies in Saudi patients with differentiated thyroid cancers
Khalid H. Al-Qahtani, Mushabbab Al-Asiri, Mutahir A. Tunio, Naji J. Aljohani, Yasser Bayoumi, Hussain Al-Hussain, Ahmed M. Maklad
Saudi Medical Journal Jan 2015, 36 (4) 442-448; DOI: 10.15537/smj.2015.4.10341

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Prevalence and treatment outcomes of second primary malignancies in Saudi patients with differentiated thyroid cancers
Khalid H. Al-Qahtani, Mushabbab Al-Asiri, Mutahir A. Tunio, Naji J. Aljohani, Yasser Bayoumi, Hussain Al-Hussain, Ahmed M. Maklad
Saudi Medical Journal Jan 2015, 36 (4) 442-448; DOI: 10.15537/smj.2015.4.10341
Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
    • Abstract
    • Methods
    • Results
    • Discussion
    • Footnotes
    • References
  • Figures & Data
  • eLetters
  • References
  • Info & Metrics
  • PDF

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • Longitudinal analysis of foodborne disease outbreaks in Saudi Arabia
  • Psychological stress and its association with bronchial asthma in Saudi Arabia
  • The factors affecting comfort and the comfort levels of patients hospitalized in the coronary intensive care unit
Show more Original Article

Similar Articles

CONTENT

  • home

JOURNAL

  • home

AUTHORS

  • home
Saudi Medical Journal

© 2025 Saudi Medical Journal Saudi Medical Journal is copyright under the Berne Convention and the International Copyright Convention.  Saudi Medical Journal is an Open Access journal and articles published are distributed under the terms of the Creative Commons Attribution-NonCommercial License (CC BY-NC). Readers may copy, distribute, and display the work for non-commercial purposes with the proper citation of the original work. Electronic ISSN 1658-3175. Print ISSN 0379-5284.

Powered by HighWire